Advanced Bionics correction
This article was originally published in The Gray Sheet
Sylmar, Calif.-based company is conducting European clinical trials of its bion miniature neurostimulator for pudendal nerve stimulation for treating urinary incontinence. So far, the device has been implanted in five patients. The firm plans to launch U.S. trials in the near future. Advanced Bionics notes that the UK National Institute of Clinical Excellence's comments on a neurostimulator for sacral implantation referred exclusively to Medtronic's InterStim, and not bion, as reported by "The Gray Sheet." The tech assessment body described the procedure for sacral nerve stimulation as one for which evidence "currently does not appear" adequate ("1The Gray Sheet" May 5, 2003, p. 19)...
You may also be interested in...
New abdominal aortic aneurysm endovascular stent grafts may increase the number of patients who undergo the procedure, according to NICE
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.